Literature DB >> 6997434

Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release.

J E Cope.   

Abstract

Miconazole at 10 micrograms ml-1 inhibited the growth of exponential phase cultures of Candida albicans and released intracellular K+. Higher concentration of miconazole were, however, required to cause cell death: at neutral pH, complete killing occurred at 30 micrograms ml-1, while at pH 3.0 or 4.5, there was only partial killing with miconazole up to 80 micrograms ml-1. Efficient killing of C. albicans by miconazole occurred both at low temperature and when cells were incubated in buffer alone. It is proposed that both the fungistatic and fungicidal actions of miconazole are due to its direct interaction with the cellular membranes of C. albicans rather than to an inhibition of biochemical reactions. Divalent cations protected C. albicans from both the fungistatic and fungicidal effects of miconazole and this was probably due to a competition between the ions and miconazole in its positively charged form for negatively charged binding sites. Candida albicans increased in resistance to miconazole-induced K+ release during the stationary phase of a batch culture. Development of this resistance required efficient aeration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997434     DOI: 10.1099/00221287-119-1-245

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  13 in total

1.  Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.

Authors:  Arturo Luna-Tapia; Morgan E Kerns; Karen E Eberle; Branko S Jursic; Glen E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

2.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Antagonism of the direct fungicidal action of miconazole by miconazole fungistasis.

Authors:  W H Beggs; I R LaSota; C E Hughes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

4.  Is it morphologic type or physiologic state that governs susceptibility of Candida albicans to clotrimazole kill?

Authors:  W H Beggs; I R LaSota; C E Hughes
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

5.  A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.

Authors:  H Sanati; P Belanger; R Fratti; M Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 6.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

7.  Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Authors:  Daisuke Kobayashi; Kei Kondo; Nobuyuki Uehara; Seiko Otokozawa; Naoki Tsuji; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Cytochrome P-450-dependent 14 alpha-demethylation of lanosterol in Candida albicans.

Authors:  C A Hitchcock; S B Brown; E G Evans; D J Adams
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

9.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

10.  Action of antifungal imidazoles on Staphylococcus aureus.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.